Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  carmustine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 441 for your search:
Start Over
PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050100, NCT00352703
Oral Zinc Therapy for the Prevention of Mucositis
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-06-4196-MKM-CTIL, NCT00449592
AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103
Phase II/III Autologous Stem Cell Reinfusion Following ARA-C/BCNU for CML in Blast Crisis
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-018-544, DFCI-80051, DFCI-CML
Phase II/III Adjuvant Therapy with High-Dose BCNU for High-Grade Malignant Glioma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 65
Sponsor:
Protocol IDs: VU-CNS-1, NCI-V85-0222
Phase II/III Randomized Comparison of DTIC/BCNU/CDDP vs DTIC/BCNU/CDDP/TMX vs CDDP/TMX in Patients with Disseminated Malignant Melanoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UCSD-88612, NCI-V89-0023
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187
Phase III Randomized Study of Crisnatol Mesylate vs BCNU in the Consolidative Treatment of Glioblastoma Multiforme (Summary Last Modified 10/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UTHSC-9235011015, SACI-IDD-003, UTHSC-IDD-003, NCI-V93-0321
Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9305, CDR0000063286, NCT00002545
Phase III Randomized Study of Carmustine With or Without Cisplatin and of Standard vs Accelerated Radiotherapy for Grade IV Gliomas
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-937252, SWOG-9503, NCCTG-93-72-52
Radiation Therapy in Treating Patients With Brain Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: Other
Protocol IDs: EORTC-26882, NCT00002620
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 to 80
Sponsor: Other
Protocol IDs: EORTC-06954, ITA-GIMEMA-AML13, NCT00002719
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-015, P30CA008748, MSKCC-96015A1, NCI-V96-0881, NCT00002766
Open-Label, Multicenter Study of Intraoperative Implantation of a Polifeprosan 20 Wafer Containing Carmustine (GLIADEL) for Recurrent Malignant Glioma (Summary Last Modified 04/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GP-100-9501, NCI-V96-0952
Combination Chemotherapy in Treating Patients With Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: DM95-047, P30CA016672, MDA-DM-95047, NCI-G96-1014, CDR0000065048, NCT00002836
Phase III Adjuvant Chemotherapy with BCNU with and without Autologous Marrow Infusion Following Surgery and Radiotherapy for Malignant Glioma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: NCI-D78-001-118, UF-777
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065658, S9704, U10CA032102, SWOG-S9704, CAN-NCIC-LY11, CALGB-59903, ECOG-S9704, LY11, NCT00004031
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9813, CDR0000067512, ECOG-R9813, NCCTG-RTOG-9813, NCT00004259
Start Over